Clinical Trial Update: Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical study of ACT-129968 in partly controlled asthma has completed; the update notes the trial status but does not include results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ACT-129968

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Asthma | Phase 2 | Status: COMPLETED